With Foresite backing $90M round, GenapSys rolls out a smaller, cheaper sequencer

GenapSys has netted a $90 million series C led by Foresite Capital to introduce a genetic sequencer that is designed to deliver high-accuracy results at low cost without the need for a central laboratory.

GenapSys Inc.'s shoebox-sized sequencer costs $10,000 and uses sensors on chips to measure the electrical signature of a reaction. In contrast, standard optical sequencers use scanners, cost about $1 million, and are about the size of a refrigerator. ...